Durable response to bevacizumab in adults with recurrent pilocytic astrocytoma.
Wasilewski, Andrea
Durable response to bevacizumab in adults with recurrent pilocytic astrocytoma. [electronic resource] - CNS oncology 07 2018 - CNS26 p. digital
Publication Type: Journal Article
2045-0915
10.2217/cns-2017-0039 doi
Adult
Antineoplastic Agents, Immunological--therapeutic use
Astrocytoma--drug therapy
Bevacizumab--therapeutic use
Brain Neoplasms--drug therapy
Female
Humans
Longitudinal Studies
Male
Models, Statistical
Neoplasm Recurrence, Local--drug therapy
Survival Analysis
Survival Rate
Durable response to bevacizumab in adults with recurrent pilocytic astrocytoma. [electronic resource] - CNS oncology 07 2018 - CNS26 p. digital
Publication Type: Journal Article
2045-0915
10.2217/cns-2017-0039 doi
Adult
Antineoplastic Agents, Immunological--therapeutic use
Astrocytoma--drug therapy
Bevacizumab--therapeutic use
Brain Neoplasms--drug therapy
Female
Humans
Longitudinal Studies
Male
Models, Statistical
Neoplasm Recurrence, Local--drug therapy
Survival Analysis
Survival Rate